Platform into Patient Impact. High-unmet need. Genuinely differentiated.
Clinical-Stage | Solid Tumor Oncology
Sentinel BioTherapeutics is advancing encapsulated protein producers (ePPs) that drive in vivo expansion of tumor-infiltrating lymphocytes (TILs) to treat patients with metastatic cancer in the peritoneal cavity.
IND-enabling | Lymphedema + Pipeline
SteerBio is advancing a first-in-class regenerative therapy aimed at repairing the lymphatic system and treating lymphedema at its source.
Advancing to Phase 1 | Recurrent Platinum Resistant Ovarian Cancer
Duracyte is advancing a novel biohybrid platform that turns implantable devices into living drug factories for sustained delivery of biologic therapies